Dan Simhon

Dan Simhon is the Co-founder and CEO of Pre-Cure, a precision medicine platform established in October 2022, which focuses on simulating physiological tumor behavior for optimal treatment outcomes. Dan was recognized as a finalist at MassChallenge Israel from February to June 2024. Previous experience includes serving as an articled clerk at Yigal Arnon & Co. from September 2020 to September 2021 and as a judicial law clerk at the Israeli National Labor Court from October 2018 to September 2019, where responsibilities included drafting court rulings and verdicts under the supervision of Honorable Judge Varda Virt-Livne. Dan holds a Master of Business Administration with a focus on Big Data Analytics and a Bachelor of Laws in Commercial Law, both from The Hebrew University of Jerusalem.